Earnings Per Share: Basic and diluted loss per share for the three-month periods ended March 31, 2025 and 2024 are calculated as follows (in thousands, except per share amounts): | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | | | | 2025 | | 2024 | Basic loss per share | | | | | | | | Numerator: | | | | | | | | Net income attributable to Albemarle Corporation | | | | | $ | 41,348 | | | $ | 2,448 | | Mandatory convertible preferred stock dividends | | | | | (41,688) | | | (11,584) | | Net loss attributable to Albemarle Corporation common shareholders | | | | | $ | (340) | | | $ | (9,136) | | Denominator: | | | | | | | | Weighted-average common shares for basic loss per share | | | | | 117,603 | | | 117,451 | | Basic loss per share | | | | | $ | (0.00) | | | $ | (0.08) | | | | | | | | | | Diluted loss per share | | | | | | | | Numerator: | | | | | | | | Net income attributable to Albemarle Corporation | | | | | $ | 41,348 | | | $ | 2,448 | | Mandatory convertible preferred stock dividends | | | | | (41,688) | | | (11,584) | | Net loss attributable to Albemarle Corporation common shareholders | | | | | $ | (340) | | | $ | (9,136) | | Denominator: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Weighted-average common shares for diluted loss per share | | | | | 117,603 | | | 117,451 | | Diluted loss per share | | | | | $ | (0.00) | | | $ | (0.08) | |
The following table summarizes the number of shares, calculated on a weighted average basis, not included in the computation of diluted earnings per share because their effect would have been anti-dilutive (in thousands): | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | | | | 2025 | | 2024 | Shares assuming the conversion of the mandatory convertible preferred stock | | | | | 21,022 | | | 6,271 | | Shares under the stock compensation plans | | | | | 1,161 | | | 896 | |
|